SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-059298
Filing Date
2021-12-03
Accepted
2021-12-03 13:38:13
Documents
15
Period of Report
2021-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-8k_20211202.htm   iXBRL 8-K 45702
2 EX-99.1 abcl-ex991_6.htm EX-99.1 13076
3 GRAPHIC go045vre0o4o000002.jpg GRAPHIC 9155
4 GRAPHIC go045vre0o4o000001.jpg GRAPHIC 34115
  Complete submission text file 0001564590-21-059298.txt   251485

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA abcl-20211202.xsd EX-101.SCH 5689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20211202_lab.xml EX-101.LAB 19325
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20211202_pre.xml EX-101.PRE 11488
8 EXTRACTED XBRL INSTANCE DOCUMENT abcl-8k_20211202_htm.xml XML 3518
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 211469484
SIC: 2834 Pharmaceutical Preparations